Results 141 to 150 of about 8,174 (197)

Comparative analysis of phytocompounds and repurposed drugs against dengue virus serotypes employing an in silico study. [PDF]

Sci Rep
Vats P, Rolta R, Salaria D, Sharma I, Verma A, Fadare OA, Verma M.   +6 more
europepmc   +1 more source

The Genotypes/Subtypes and Antiviral Drug Resistance of the Hepatitis C Virus from Patients in a Tertiary Care Hospital in Nepal. [PDF]

Viruses
Kattel HP, Sharma S, Alfsnes K, Pettersson JH, Pathak R, Engebretsen SB, Rijal KR, Ghimire P, Andreassen ÅK, Banjara MR.   +9 more
europepmc   +1 more source

Directly acting antivirals improve insulin resistance in nondiabetic patients with hepatitis C: a systematic review and meta-analysis. [PDF]

Ann Med Surg (Lond)
Lamichhane P, Makhlouf SSK, Saleem K, Senliya D, Wajid A, Khanal K, Agrawal A.   +6 more
europepmc   +1 more source

Drug-Target Interaction Prediction via Dual-Interaction Fusion. [PDF]

Molecules
Li X, Li Z, Wei B, Zeng Y.
europepmc   +1 more source

Autoimmune Hepatitis After Successful Treatment of Chronic Hepatitis C Virus Infection with Direct-Acting Antivirals: A Pediatric Case Report. [PDF]

Pathogens
Talarek E, Aniszewska M, Dobrzeniecka A, Kmiotek J, Pokorska-Śpiewak M.   +4 more
europepmc   +1 more source

Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications [PDF]

core   +1 more source

Assessment of direct-acting antiviral treatment outcomes in patients with chronic hepatitis C infected with various HCV genotypes: Insights from a real-world cohort in West Bengal, India. [PDF]

BMC Infect Dis
Dutta S, Nath S, Das R, Bakshi S, Majumdar M, Ghosh A, Baskey U, Chowdhury PK, Sadhukhan PC.   +8 more
europepmc   +1 more source

Hepatitis C virus NS3/4A protease cleaves SPG20, a key regulator of lipid droplet turnover, to promote lipid droplet formation. [PDF]

J Virol
Matsui C, Yuliandari P, Deng L, Abe T, Shoji I.   +4 more
europepmc   +1 more source

High efficacy and safety of direct-acting antivirals for the treatment of chronic hepatitis C: A cohort study conducted in Vietnam. [PDF]

Pharmacol Res Perspect
Vo TD, Bui VTT, Lam HT, Bui QTH.
europepmc   +1 more source

Alternative Pharmaceutical Innovation Models in Competitive Markets: A Collaborative Approach to Develop a Novel Drug for Hepatitis C. [PDF]

Trop Med Infect Dis
Vieira M, Slovenski I, Large K, Alonso Ruiz A, Moon S.   +4 more
europepmc   +1 more source